Telehealth Referral to Improve Outcomes

Telehealth Referral to Improve Outcomes for Asymptomatic Hypertension in the Emergency Department

Status

Suspended

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05000970

Acronym

TRIO

Enrollment

Registered

2021-08-11

Start date

2021-07-12

Completion date

2024-04-30

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Asymptomatic hypertension, Referral, Telehealth, Remote patient monitoring, Emergency Department, blood pressure

Brief summary

Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital Tech, on blood pressure control and primary care engagement.

Detailed description

Emergency Department (ED) clinicians encounter patients with asymptomatic hypertension (HTN) on a daily basis but usually fail to intervene. This pilot study will determine the utility of a novel intervention: Telehealth Referral to Improve Outcomes (TRIO), a conceptually driven information technology tool focused on patients who are asymptomatic and hypertensive upon ED discharge. It is designed to successfully link them to a primary care provider (PCP) after ED discharge to improve blood pressure (BP) control. 48 adult ED patients who have asymptomatic HTN (BP \>/= 140/90 mmg and \</= 180/120 mmHg) and who will be discharged will be enrolled in the study. This study is a single-site, 3-arm randomized controlled pilot trial. All patients will receive a wireless BP monitor and tablet. Group 2 (N=16) will additionally receive a telehealth consult with an RN at day 3. Group 3 (N=16) will additionally receive a telehealth consult with an RN at day 3 and day 7. The research team will collect feasibility outcomes: (recruitment rate, retention rate, and attrition rate of patients enrolled in TRIO at 6-months and 12-months. The research team will evaluate BP control and engagement with primary care at 6-months and 12-months and compare between groups.

Interventions

DEVICEblood pressure cuff PLUS tablet

all arms

OTHERTelehealth Consult

Telehealth consult with an RN

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Investigator)

Masking description

Both participant and investigator will be blinded on the study assignment group.

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years * At least two\* high blood pressure readings during ED visit 1. Systolic (top #) ≥140, ≤180 AND/OR 2. Diastolic (bottom #) ≥ 90, ≤120 \*Second blood pressure may be confirmed when approaching the patient. Before approaching, check exclusions first.

Exclusion criteria

* symptomatic hypertension

Design outcomes

Primary

Measure	Time frame	Description
Recruitment rate	6 months	recruitment rate of patients enrolled in TRIO at 6-months.
Retention rate	6 months	retention rate of patients enrolled in TRIO at 6-months.
Attrition rate	6 months	attrition rate of patients enrolled in TRIO at 6-months.

Secondary

Measure	Time frame	Description
Blood pressure	6 months	—
Number of participant who had follow up care	6 months	Primary Care Engagement to be defined as having follow up care (yes/no) at 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026